Aug
2026
COEX, Seoul, Korea
Visit us
stand EG07

Bioworkshops

Exhibitor at CPHI Korea 2026
About Us

Bioworkshops is a full-service contract development and manufacturing organization (CDMO) for antibody products. Our services include development and cGMP manufacturing of drug substance and final product:

  • cell lines
  • process development
  • analytical methods
  • formulation
  • process characterization/validation
  • 13,000L of single-use cell culture capacity (200L to 2000L)
  • 3 aseptic filling lines (vials, lyophilized, PFS/Cartridges) up to 100,000 units/batch
  • product testing
  • CTD dossiers

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Start-up
Primary activities
Biopharmaceutical
View company profile
Contact info
  • +86-15618259078
  • No. 5, Dongwang Road,, Suzhou Industrial Park, Suzhou, China
Show contact info Hide contact info
Event information
CPHI Korea 2026
  • 25 Aug 2026 - 27 Aug 2026
  • COEX, Seoul, Korea
  • Visit us at stand EG07

Products Featured at CPHI Korea 2026

  • Adalimumab

    Product Adalimumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Anifrolumab

    Product Anifrolumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Atezolizumab

    Product Atezolizumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Bamlanivimab

    Product Bamlanivimab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Bebtelovimab

    Product Bebtelovimab

    Target: SARS-CoV-2 S protein CAS: 2578319-11-4

Bioworkshops Resources (1)